Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jeremy D Rubinstein (Jeremy Rubinstein)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 18

Top Venues

Pediatric blood & cancer

Blood advances

EJHaem

British journal of haematology

Cincinnati Children's Hospital Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cincinnati Children's Hospital Medical Center

United States

Assistant Professor :: Division of Oncology

Publications

Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer (2023)
Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer 70 (4) (2023)
Thomas J Galletta, Jeremy D Rubinstein, Christa Krupski, Adam S Nelson, Ruby Khoury, Christopher E Dandoy, Stella M Davies, Christine L Phillips
Durable remissions achieved with reinfusion of CD19-directed CAR-T despite failure to induce or maintain B-cell aplasia and single-center experience with reinfusion of tisagenlecleucel. Pediatric blood & cancer 70 (5) (2023)
Thomas J Galletta, Jeremy D Rubinstein, Christa Krupski, Adam S Nelson, Ruby Khoury, Christopher E Dandoy, Stella M Davies, Christine L Phillips
Durable remissions achieved with reinfusion of CD19-directed CAR-T despite failure to induce or maintain B-cell aplasia and single-center experience with reinfusion of tisagenlecleucel. Pediatric blood & cancer 70 (5) (2023)
Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer 70 (4) (2023)
Thomas J Galletta, Jeremy D Rubinstein, Christa Krupski, Adam S Nelson, Ruby Khoury, Christopher E Dandoy, Stella M Davies, Christine L Phillips
Durable remissions achieved with reinfusion of CD19-directed CAR-T despite failure to induce or maintain B-cell aplasia and single-center experience with reinfusion of tisagenlecleucel. Pediatric blood & cancer (2023)
Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer 70 (4) (2023)
Anthony Sabulski, David D Grier, Kasiani C Myers, Stella M Davies, Jeremy D Rubinstein
Acute myeloid leukemia in SRP54 -mutated congenital neutropenia. EJHaem 3 (2) (2022)
Jeremy D Rubinstein, Carolyn Lutzko, Thomas Leemhuis, Xiang Zhu, Giang Pham, Lorraine Ray, Shawn Thomas, Celeste Dourson, Jamie Wilhelm, Adam Lane, Jose A Cancelas, Dakota Lipps, Justin Ferrell, Patrick J Hanley, Michael D Keller, Catherine M Bollard, YunZu Michele Wang, Stella M Davies, Adam S Nelson, Michael S Grimley
Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant. Blood advances 6 (9) (2022)
Zeinab A M Afify, Manuela A Orjuela-Grimm, Christine Moore Smith, Mansi Dalal, James B Ford, Pallavi Pillai, Joanna M Robles, Sonika Reddy, Sarah McCormack, Matthew J Ehrhardt, Tonya Ureda, Warren Alperstein, Holly J Edington, Tamara P Miller, Jeremy D Rubinstein, Madison Kavanaugh, Andrew J Bukowinski, Erika Friehling, Julie M Rivers, Karen M Chisholm, Lianna J Marks, Clinton C Mason
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative. British journal of haematology (2022)
Jeremy D Rubinstein, Xiang Zhu, Thomas Leemhuis, Giang Pham, Lorraine Ray, Sana Emberesh, Sonata Jodele, Shawn Thomas, Jose A Cancelas, Catherine M Bollard, Patrick J Hanley, Michael D Keller, Olivia Grimley, Diana Clark, Teri Clark, Cecilia S Lindestam Arlehamn, Alessandro Sette, Stella M Davies, Adam S Nelson, Michael S Grimley, Carolyn Lutzko
Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted. Blood advances 5 (17) (2021)
Jeremy D Rubinstein, Rachana Shah, Erin H Breese, Karen C Burns, Jennifer L Mangino, Robin E Norris, Lynn Lee, Benjamin Mizukawa, Maureen M O'Brien, Christine L Phillips, John P Perentesis, Lauren Pommert, Michael J Absalon
Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective. Pediatric blood & cancer 68 (8) (2021)
Myesa Emberesh, Jeremy D Rubinstein, Jennifer Young, Stefanie W Benoit, Christopher E Dandoy, Brian D Weiss
Tolerance of dinutuximab therapy for treatment of high-risk neuroblastoma in two patients with end-stage renal disease on dialysis. Pediatric blood & cancer 68 (3) (2020)
Jeremy D Rubinstein, Adam S Nelson, Christa Krupski, William O'Brien, J Michael Taylor, Tom C Badgett, Michael Huang, Stella M Davies, Christine L Phillips
Chimeric antigen receptor T-cell therapy in patients with neurologic comorbidities. Pediatric blood & cancer 67 (4) (2020)
Jeremy D Rubinstein, Anita Gupta, Sara Szabo, Joseph G Pressey
A case of submandibular desmoplastic small round cell tumor: Diagnostic and management approaches to an atypical presentation of a rare tumor. Pediatric blood & cancer 67 (4) (2020)
Jeremy D Rubinstein, Karen Burns, Michael Absalon, Carolyn Lutzko, Tom Leemhuis, Sharat Chandra, Patrick J Hanley, Michael D Keller, Stella M Davies, Adam Nelson, Michael Grimley
EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects. Pediatric blood & cancer 67 (3) (2019)
Jeremy D Rubinstein, Joseph G Pressey, Melissa Klein
Expanding the pediatric oncology medical home: Successful utilization of a medical-legal partnership at a pediatric oncology referral center. Pediatric blood & cancer 66 (5) (2019)
Donald J Lucas, Jeremy D Rubinstein, Ankush Gosain, Greg Tiao, Tim Head, J Nick Pratap, Regan Williams, Sara Helmig, James I Geller, Max Langham, Angela D Trobaugh-Lotrario
Surgical and anesthetic management for hepatectomy in two pediatric patients with trisomy 18, pulmonary hypertension, and hepatoblastoma. Pediatric blood & cancer 66 (6) (2019)

Jeremy D Rubinstein.css-eqlu8i{font-size:small;padding-left:4px;} (Jeremy Rubinstein)

Publication Activity (10 Years)

Top Topics

Top Venues

Jeremy D Rubinstein (Jeremy Rubinstein)